Morocco celebrated International Rare Disease Day with the launch of a new Precision Medicine Hub at the Mohammed VI International University Hospital Complex on Friday in Rabat, a joint project by Fondation Mohammed VI des Sciences et de la Santé (FM6SS) and AstraZeneca. 

The Hub aims to improve the diagnosis, treatment, and care coordination for patients living with rare diseases while expanding access to advanced medicine technologies.

The event brought together institutional representatives and civil society members, including the Moroccan Society of Medical Genetics and the Moroccan Alliance for Rare Diseases. 

This gathering followed the Memorandum of Understanding signed in July 2025 between FM6SS and AstraZeneca to establish a Rare Diseases Center of Excellence (RD CoE). 

The two institutions joined forces to shorten diagnostic delays, create structured multidisciplinary care pathways, and incorporate genomic and molecular profiling into routine clinical practice.